Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report Medical Dialogues Bureau5 Sept 2019 9:00 AM ISTBilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
GSK Belantamab Mafodotin shows to help blood cancer patients Medical Dialogues Bureau26 Aug 2019 9:15 AM ISTTwo doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 9:30 AM ISTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 9:30 AM ISTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 9:40 AM ISTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1 Farhat Nasim2 Aug 2019 9:15 AM ISTThe company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
GSK drug Zejula helps ovarian cancer patients live longer in late-stage study Medical Dialogues Bureau16 July 2019 9:26 AM ISTGSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL Farhat Nasim29 Jun 2019 11:56 AM ISTThe court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
GSK eyes sale of $1.2 billion consumer health drugs; says report Medical Dialogues Bureau22 Jun 2019 8:59 AM ISTGSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 2:06 PM ISTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
GSK Nucala wins USFDA approval for two new self-administration options Farhat Nasim9 Jun 2019 10:00 AM ISTNucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
GSK Consumers Healthcare gets shareholders' nod for merger with HUL Medical Dialogues Bureau3 Jun 2019 9:30 AM ISTEarlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
